Connor, Clark & Lunn Investment Management (CC&L)
RDUS

Connor, Clark & Lunn Investment Management (CC&L)’s Radius Health, Inc. RDUS Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio RDUS Stock Details RDUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-50,871
Closed -$528K – 1297
2022
Q2 		$528K Sell
50,871
-29,892
-37% -$222K ﹤0.01% 763
2022
Q1 		$713K Buy
80,763
+58,797
+268% +$446K ﹤0.01% 721
2021
Q4 		$152K Buy
+21,966
New +$322K ﹤0.01% 1007

Other funds holding RDUS

RCG
Rock Creek Group Washington, District of Columbia $994M AUM 11.29% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s RDUS Position: Q3 2022 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 50,871 shares — an estimated $528K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in RDUS in Q4 2021 and held it in 3 quarters. The position peaked at $713K in Q1 2022. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 50,871 Radius Health, Inc. shares in Q3 2022, an estimated $528K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Radius Health, Inc. in Q4 2021 and held it in 3 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Radius Health, Inc. position peaked at $713K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2022, filed 10 Nov 2022.